Subcutaneous hormone implants for the control of climacteric symptoms. A prospective study.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  The Lancet

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 6140343
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HORMONAL PROFILES IN POSTMENOPAUSAL WOMEN AFTER THERAPY WITH SUBCUTANEOUS IMPLANTS

  1981cited by this paper
• Ovarian failure and ageing.

  1981cited by this paper
• Procedures in practice. Hormone implantation.

  1980cited by this paper
• Prevention and treatment of endometrial disease in climacteric women receiving oestrogen therapy.

  1979cited by this paper
• Hormonal profiles after the menopause.

  1976cited by this paper
• Indications for hormonal pellets in the therapy of endocrine and gynecic disorders.

  1949cited by this paper

• Compounded hormonal pellets: a critical review of current evidence and risks

  2025cites this paper
• Testosterone Pellets in Women: Revisiting Safety and Clinical Outcomes

  2025cites this paper
• Subcutaneous hormone implants

  2023cites this paper
• Testosterone for women: certainties and uncertainties

  2022cites this paper
• Reproductive depression

  2012cites this paper
• A guide to the treatment of depression in women by estrogens

  2011cites this paper
• Reproductive aging, sex steroids, and mood disorders.

  2009cites this paper
• Neurobehavioral impact of menopause on mood

  2007cites this paper
• Effects of aromatase inhibition on sexual function and well-being in postmenopausal women treated with testosterone: a randomized, placebo-controlled trial

  2006cites this paper
• The Association of Perimenopausal Mood Disorders with Other Reproductive-Related Disorders

  2005cites this paper
• The endocrinology of sexual arousal.

  2005cites this paper
• Testosterone for peri- and postmenopausal women.

  2005cites this paper
• Androgen insufficiency in women: diagnostic and therapeutic implications.

  2004cites this paper
• Effect of Raloxifene on Sexual Function in Older Postmenopausal Women With Osteoporosis

  2003cites this paper
• What is the Rationale for Androgen Therapy for Women?

  2003cites this paper
• Continuation of hormone replacement therapy after hysterectomy

  2003cites this paper
• Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women

  2003cites this paper
• Sexual effects of androgens in women: some theoretical considerations.

  2002cites this paper
• Hormonal influence on the central nervous system.

  2002cites this paper
• The effects of tibolone on mood and libido

  2002cites this paper
• Basal plasma hormone levels in depressed perimenopausal women.

  2002cites this paper
• Role of Estrogen in the Aetiology and Treatment of Mood Disorders

  2001cites this paper
• Correlation between serum testosterone levels and peripartal mood states

  2001cites this paper
• Testosterone influences libido and well being in women.

  2001cites this paper
• A Preliminary Study of Hormone Replacement Therapy and Psychological Mood States in Perimenopausal Women

  2001cites this paper
• Evaluation of combining kava extract with hormone replacement therapy in the treatment of postmenopausal anxiety.

  2001cites this paper
• HRT and its impact on the menopause, osteoporosis and breast cancer

  2000cites this paper
• Hormonal aspects of sexual dysfunction: The therapeutic use of exogenous androgens in men and women

  2000cites this paper
• Patients' outlook, experience, and satisfaction with hysterectomy, bilateral oophorectomy, and subsequent continuation of hormone replacement therapy.

  2000cites this paper
• Sexual dysfunction in depression

  2000cites this paper
• The importance of obtaining a sexual history.

  2000cites this paper
• The psychological outcome of hysterectomy

  2000cites this paper
• Is there a hormonal basis to hysterectomy‐related depression?

  1999cites this paper
• Endogenous Levels of Dehydroepiandrosterone Sulfate, but Not Other Sex Hormones, Are Associated with Depressed Mood in Older Women: The Rancho Bernardo Study

  1999cites this paper
• Menopause and the central nervous system: intervention options.

  1999cites this paper
• CURRENT HORMONE REPLACEMENT THERAPY: WHAT ARE THE SHORTCOMINGS? ADVANCES IN DELIVERY

  1999cites this paper
• Sex playing with the mind. Effects of oestrogen and testosterone on mood and cognition.

  1999cites this paper
• Hormonal treatment and psychological function during the menopausal transition: an evaluation of the effects of conjugated estrogens/cyclic medroxyprogesterone acetate.

  1998cites this paper
• Hysterectomy, ovarian failure, and depression.

  1998cites this paper
• Estrogen, serotonin, and mood disturbance: where is the therapeutic bridge?

  1998cites this paper
• Changes in bone collagen markers and in bone density in hormone treated and untreated postmenopausal women.

  1997cites this paper
• Newer HRT regimens

  1997cites this paper
• Adequacy of hormone replacement therapy for osteoporosis prevention assessed by serum oestradiol measurement, and the degree of association with menopausal symptoms.

  1997cites this paper
• Estrogen-androgen for hormone replacement. A review.

  1997cites this paper
• The Perimenopause and Affective Disorders

  1997cites this paper
• Who understands the menopause?

  1997cites this paper
• Psychological and sexual aspects of the menopause and HRT.

  1996cites this paper
• Menopause: its epidemiology and potential association with chronic diseases.

  1995cites this paper
• Exogenous androgens in postmenopausal women.

  1995cites this paper
• An audit of oestradiol levels and implant frequency in women undergoing subcutaneous implant therapy

  1995cites this paper
• Changes in sex behaviour after menopause: effects of tibolone.

  1995cites this paper
• Oophorectomy at the same time as hysterectomy

  1995cites this paper
• Methodological review and meta-analysis of sexuality and menopause research.

  1995cites this paper
• Psychological and Sexual Symptoms Associated with the Menopause and the Effects of Hormone Replacement Therapy

  1995cites this paper
• Alternatives to oral estrogen replacement. Transdermal patches, percutaneous gels, vaginal creams and rings, implants, other methods of delivery.

  1994cites this paper
• Oestradiol and testosterone implants.

  1993cites this paper
• Postmenopausal oestrogen replacement therapy with subcutaneous oestradiol implants.

  1993cites this paper
• Dependence and oestrogen replacement.

  1992cites this paper
• Effect of 17 beta-oestradiol on lymphocyte subpopulations, delayed cutaneous hypersensitivity responses and mixed lymphocyte reactions in post-menopausal women.

  1992cites this paper
• The effects of plasma estradiol levels on increases in vertebral and femoral bone density following therapy with estradiol and estradiol with testosterone implants

  1992cites this paper
• Women with climacteric symptoms: A target group for prevention of rapid bone loss and osteoporosis

  1992cites this paper
• Drug dependence with oestrogen replacement therapy.

  1992cites this paper
• A first study to compare two dosages of dydrogesterone in opposing the 50 mg oestradiol implant.

  1991cites this paper
• Hormone implants and tachyphylaxis

  1991cites this paper
• Hormonal replacement therapy for postmenopausal women: A review of sexual outcomes and related gynecologic effects

  1990cites this paper
• Depression and the menopause.

  1990cites this paper
• Oestrogen therapy for the menopause

  1990cites this paper
• Hysterectomy and menorrhagia.

  1989cites this paper
• Prophylactic oophorectomy

  1989cites this paper
• Symptoms of oestrogen deficiency in women with oestradiol implants.

  1989cites this paper
• Menopause--a multi system disease.

  1988cites this paper
• Research Policy: Medical researchers: training and straining

  1988cites this paper
• Response of skin thickness and metacarpal index to estradiol therapy in postmenopausal women

  1987cites this paper
• Metabolic and Hormonal Effects of 25‐mg and 50‐mg 17β‐Estradiol Implants in Surgically Menopausal Women

  1987cites this paper
• Effects of subcutaneous oestradiol implants on ovarian activity

  1987cites this paper
• Skin Collagen Changes in Postmenopausal Women Receiving Different Regimens of Estrogen Therapy

  1987cites this paper
• The role of androgen in the maintenance of sexual functioning in oophorectomized women.

  1987cites this paper
• Hormone pellet implantation for the menopause and premenstrual syndrome.

  1987cites this paper
• Women and mental illness.

  1986cites this paper
• THE EFFECT OF TRANSDERMAL OESTROGEN ON BONE, CALCIUM‐REGULATING HORMONES AND LIVER IN POSTMENOPAUSAL WOMEN

  1986cites this paper
• Long-Term Hormone Implant Therapy—Hormonal and Clinical Effects

  1986cites this paper
• Climacteric flushing in a patient with carcinoid tumour.

  1985cites this paper
• Long‐term effects of the menopause and sex hormones on skin thickness

  1985cites this paper
• Haematuria in patients with haemostatic defects.

  1985cites this paper
• Endometrial and menstrual response to subcutaneous oestradiol and testosterone implants and continuous oral progestogen therapy in post-menopausal women.

  1985cites this paper